Millets National Media Portal
Millets National Media Portal
Emerging nutritional research supports the incorporation of millets into the diets of cancer patients undergoing chemotherapy. Their multi-modal nutritional properties address many of the metabolic challenges induced by chemotherapy treatment. According to a 2023 review in Cureus, millets are 'widely accessible, cost-effective, nutrient-dense, high in fiber, gluten-free, anti-inflammatory, antioxidant, and have lipid-lowering and gastro-protective properties' — all relevant to cancer supportive care.
How millets benefit chemotherapy patients:
Immunomodulation: Iron, zinc, and selenium in millets support immune function depressed by chemotherapy drugs.
Anti-inflammatory: Polyphenols reduce chemotherapy-induced systemic inflammation and oxidative stress.
Gut protective: Prebiotic fiber supports gut microbiota recovery after antibiotic and chemotherapy-induced dysbiosis; fiber also protects the intestinal lining.
Anti-nausea (limited): Easily digestible millet porridges (proso or foxtail) are gentle on the stomach during chemotherapy-induced nausea.
Antioxidant protection: High antioxidant content may help neutralize free radicals generated by some chemotherapy agents.
Nutritional density without aggravation: Gluten-free, low-allergen profile makes millets suitable for patients with treatment-induced sensitivities.
Important caution: Antioxidant supplementation during chemotherapy remains controversial; cancer patients must consult their oncologist before making significant dietary changes — millets as whole food (not extract/supplement) are generally considered safe.
© 2023 - 2026 Millets News. All rights reserved.
